Immunome (IMNM) Non Operating Income (2019 - 2020)
Immunome (IMNM) reported Non Operating Income of -$11.2 million for Q4 2020, down 32900.0% on a YoY basis from N/an in Q1 2020, and down 300.61% quarter-over-quarter from $5.6 million in Q3 2020.
Immunome (IMNM) Non Operating Income (2019 - 2020) Analysis & Trends
Immunome has reported Non Operating Income for 2 years, with the latest figure at -$11.2 million in Q4 2020.
- For the quarter ending Q4 2020, Non Operating Income fell 32900.0% year-over-year to -$11.2 million; the trailing twelve-month figure through Dec 2020 stood at -$5.5 million (changed N/A YoY), and the FY2022 full-year result was $5000.0, down 98.99% from the prior year.
- Non Operating Income for Q4 2020 stood at -$11.2 million, down from $5.6 million in the prior quarter.
- The five-year high for Non Operating Income was $5.6 million in Q3 2020, with the low at -$11.2 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Immunome | 2.12 Bn | 1.54 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -11.15 Mn |
| Sep 30, 2020 | 5.56 Mn |
| Dec 31, 2019 | 34,000.00 |
| Sep 30, 2019 | 17,000.00 |